Skip to NavigationSkip to content

MSD's Deepak Khanna to chair American Pharmaceutical Group

Published on: 17/03/11

Merck Sharp and Dohme’s UK managing director Deepak Khanna has been appointed chairman of the American Pharmaceutical Group.

The APG is a trade association for the seven largest US research-based biopharmaceutical companies operating in the UK - Abbott, Amgen, BMS, Janssen, Lilly, MSD and Pfizer.

Deepak said: “We are going through a period of almost unprecedented policy change in the UK, including major NHS structural reform, a new medicines’ pricing system and the Cancer Drugs Fund.

“Throughout this time, the APG has an important role. We must work closely with the ABPI and others in industry and the government to ensure the result is the right operating environment in the UK. Only this will lead to the best possible health outcomes for patients and associated benefits to the UK’s economy. I look forward to working towards this goal.”

Deepak was appointed UK managing director of MSD in 2009, having previously served as general manager of Merck/Schering-Plough Pharmaceuticals in the US.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches